Clinical trial
An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a…
NCT00330850 · ProEthic Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00330850 |
|---|---|
| Title | An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack |
| Lead sponsor | ProEthic Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine, Photophobia, Phonophobia |
| Intervention type | Drug |
| Interventions | PRO-513 |
| Enrollment | 650 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | May 29, 2006 |
| Last update posted | Apr 2, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: